Keyphrases
Lymph Node Metastasis
100%
Lymphovascular Invasion
100%
Radical Cystectomy
100%
Pathologic
63%
Transurethral Resection of Bladder Tumor (TURBT)
36%
Overall Survival
27%
Statistical Analysis
18%
National Cancer Database
18%
Lymph Node Positive
18%
Histology
9%
High Risk
9%
Risk Model
9%
Chemotherapy
9%
Poor Prognosis
9%
Bladder
9%
Node-positive
9%
Hypothesis Testing
9%
Metastatic Disease
9%
Bladder Cancer
9%
Stata
9%
Pelvic Lymph Node Dissection
9%
Measurement Analysis
9%
Clinical Decision-making
9%
Upper Tract Urothelial Carcinoma
9%
Tumor Specimens
9%
Lymph Node Dissection
9%
Urothelial Carcinoma
9%
Node-positive Disease
9%
Muscle-invasive Bladder Cancer
9%
Positive Rate
9%
Survival Stage
9%
Medicine and Dentistry
Lymph Node Metastasis
100%
Lymphovascular Invasion
100%
Cystectomy
100%
Overall Survival
27%
Transurethral Resection
27%
Bladder Tumor
27%
Malignant Neoplasm
18%
Clinical Stage
18%
Bladder
18%
Lymph Node
18%
Retroperitoneal Lymph Node Dissection
18%
Transitional Cell Carcinoma
18%
Metastatic Carcinoma
9%
Pelvis
9%
Bladder Cancer
9%
Outcome Assessment
9%
Clinical Decision Making
9%
Muscle Invasive Bladder Cancer
9%
Diseases
9%